by TractManager | Feb 4, 2021 | News
The Food and Drug Administration (FDA) reports that preliminary results from a safety clinical trial show an increased risk of serious heart-related problems and cancer with Xeljanz/Xeljanz XR (tofacitinib; Pfizer) compared with tumor necrosis factor (TNF)...
by TractManager | Feb 4, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on the use of prophylactic negative pressure wound therapy (NPWT) as an alternative to standard primary closure of open abdominal wounds following elective surgery with the goal of preventing surgical site infections...
by TractManager | Feb 2, 2021 | Health Technology Assessment
Focus of the Report: This report focuses on the HCV-FibroSure blood test for detection and staging of liver damage in patients infected with hepatitis C virus (HCV).Technology Description: The FibroSure test (marketed as FibroTest outside the United States) measures...
by TractManager | Feb 1, 2021 | News
The Food and Drug Administration (FDA) has announced a recall of all lots of Penumbra JET 7 Reperfusion Catheter with Xtra Flex Technology, also known as JET 7 Xtra Flex.As a component of the Penumbra System with the Penumbra Aspiration Pump and Penumbra Aspiration...
Recent Comments